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1. Summary 
Routine isolation of grey horse melanoma cells and establishment of cell lines is the basis for 
any successful investigation of an effective modern therapy of this very common tumor in 
horses. Cell culture is the method to grow cells in a synthetic environment. Melanoma cell 
cultures exist of melanomas in swine, dogs, cats, mice, fish, and humans. No equine 
melanoma cell cultures have been described to date. In this report, a method to cultivate grey 
horse melanoma cells is described. Seven of 17 melanomas from 14 horses (success rate: 41%) 
were successfully transformed into a permanently growing cell line by enzymatic digestion with 
dispase and collagenase. The original tumors of successful cell lines were excised from the 
perianal region, tail base, and head. The melanomas were confirmed histologically and 
examined for association with successful/unsuccessful outcomes of the cell culture. Adherence 
was observed after 2-18 days. Confluency was reached after 10-100 days. The cells grew as 
adherent monolayers. They were of spindle shape and had long dendritic processes. Pigment 
production was evident. It accumulated extracellularly in the center of cell clusters. Successful 
isolation of grey horse melanoma cells is possible with this method. Further experiments to 
characterize the cells and to improve the isolation protocol are recommended. 
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2. Introduction 
Equine melanoma is a common dermal tumor of grey horses.[1, 2] The term equine melanocytic 
tumor is synonymous with equine melanoma. The prevalence of this tumor is up to 15% of 
equine skin tumors.[3] It is estimated that 80% of grey horses over 15 years of age develop 
melanoma.[4] The high incidence of melanoma in grey horses is thought to be related to 
changes in melanin metabolism associated with aging.[5-8] Usually they appear at the age of 5 
years, corresponding to the coat color changes. There is a loss of melanin pigment in the hair 
follicles, which results in a grey hair appearance.[3, 4, 9] No gender predilection exists.[3] Primary 
tumors are most frequently found in the perineal region, ventral tail, and external genitalia. 
Less common sites are limbs, neck, region of the parotid salivary gland, head, and eyes.[3, 10-12] 
They tend to grow slowly and usually are multicentric and locally invasive. The size varies from 
less than 1 cm to 20 cm in diameter. Metastases can occur to virtually any site with regional 
lymph nodes and the lungs as the most common internal organ systems affected.[11, 13] 
 
There are 4 syndromes of equine melanoma. Three of them have a potential for metastasis.[10] 
The first two categories are dermal melanoma and dermal melanomatosis, which are 
histologically similar, but clinically different. (i) Dermal melanomas are solitary, discrete lesions 
in which surgical excision is usually curative with a low incidence of metastasis.[1] (ii) Dermal 
melanomatosis is the term used for multiple, coalescing, not surgically excisable lesions 
occurring in typical locations in grey horses older than 15 years. They are reported to have a 
high incidence of metastasis.[10] Both types of melanomas are difficult to distinguish from each 
other and their metastatic potential can not be determined by histologic analysis.[11] (iii) 
Anaplastic malignant melanomas occur in non-grey horses and commonly develop lethal organ 
metastasis.[14, 15] (iv) Melanocytic nevi are benign, discrete, superficial, pigmented lesions in 
younger horses of all colors. Surgical excision is usually curative.[10] Approximately 95% of 
melanocytic tumors are benign at the time they are identified in a horse.[16] However, two-thirds 
are thought to progress to malignancy and are capable of widespread metastasis.[17, 18] It has 
been reported that melanomas in non-grey horses are more likely to be malignant.[19-21] 
Diagnosis of equine melanoma is based on clinical, cytologic, and histopathologic 
examination.[16] Frequently melanomas are not treated because of the initial benign behavior, 
slow-growing nature of the neoplasm, size, proximity to major vessels and vital structures, or 
extensive local invasion.[11] There may be an increased risk of metastasis after mechanical 
stimulation of a melanoma.[22] Treatment options include surgical excision,[23-25] partial tail 
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amputation,[11] cryotherapy,[26] oral systemic therapy with cimetidine,[11, 27, 28] intralesional 
chemotherapy with cisplatin,[29] and treatment with unspecific immunomodulators such as BCG 
(Bacillus Calmette-Guérin).[5] Except for total surgical excision of small and well demarcated 
melanomas,[30] which have a good prognosis, treatment success is rather poor or palliative at 
the most. In recent years human and veterinary tumor treatment research has focused on 
autogenous vaccines. A crude whole-cell melanoma vaccine has been used with mixed results 
in managing equine neoplasia.[5, 11] Intratumoral injection of interleukin-18-DNA and partially 
interleukin-12-DNA had an inhibitory effect on melanoma growth in grey horses.[31, 32] Prognosis 
for complete remission usually is grave. Problems arise when primary tumors or metastases 
compress internal organs and lead to problems with physiological function such as respiration, 
defecation, or nerve conduction.[11, 33-40] Pulmonary or visceral metastases can be life-
threatening.[3] Large superficial tumors may ulcerate and become infected. Interference of 
external tumors with riding gear may render a horse useless for its intended use.  
 
To investigate immunobiologic and pathobiologic features of equine melanocytic tumors it is 
necessary to dispose of equine melanoma cell lines. Readily available equine melanoma cell 
lines would provide good resources for further investigations on equine melanoma therapy. 
Cell culture is a method to grow cells of organic origin in a synthetic environment.[41] A primary 
cell culture consists of cells that derive from an original, intact tissue. Primary cell cultures 
typically will have a finite life span in culture. After the primary cell culture is sub-cultured it is 
termed a cell line. A cell line can become a permanently established cell culture that will 
proliferate indefinitely with the appropriate maintenance. One method to isolate cells from the 
original tissue is enzyme digestion with proteolytic enzymes. Culture conditions such as growth 
medium, temperature, oxygen concentration, carbon dioxide concentration, pH, and osmolality 
vary for each cell type. In general, the closer the artificial conditions mimic the original 
environment the better the cells grow. Some cells grow without attachment to a surface and 
proliferate in suspension. However, most cells are anchorage dependent, meaning they require 
attachment to a substrate to proliferate. The culture medium is probably the most important 
factor in culturing animal cells. It provides nutrients, pH, and osmolality. A large number of 
various cell culture basal media are available commercially. It is common practice to 
supplement the basal medium with additives such as animal sera, amino acids, and 
antibiotics.[42] Optimal culture conditions for cell growth of mammalian cells are a pH of 7.2-
7.5, an osmolality of 280-320 mOsm/kg, a temperature of 35-37 °C, and a carbon dioxide 
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concentration of 2-5% in air.[43] The use of a humidified incubator with 5% CO2 usually 
provides suitable environmental conditions. 
 
Establishment of permanent melanoma cell lines has been reported in various animal species. 
A total of 66 cell lines derived from 21 porcine melanotic lesions were studied over their life 
spans of up to 14 months.[44] The lesions were of cutaneous and visceral origin. Eight canine 
melanoma cell lines were established from tissues of 6 dogs with oral melanomas and 
metastatic lesions to liver and lymph nodes.[45] They had been maintained in culture for longer 
than 1 year. Seven other attempts to establish cell lines were unsuccessful because either they 
did not grow or fibroblast overgrowth was present. Other canine melanoma cell lines were 
established from canine skin melanomas,[46] oral melanomas,[47] and lung metastases.[48] Of the 
infrequent cat melanoma 3 cell lines were established from the primary throat tumor and from 
metastatic lung and heart tumors of the same animal.[49] The author mentioned that long-term 
cultures of feline tumors are difficult to establish because of  cytopathic viruses in cat tissue 
that destroy the cultures. Numerous murine cell lines are available commercially.[50] An 
amelanotic melanoma obtained from a tail fin of a platyfish-swordtail hybrid fish was 
successfully transformed to a cell line, which was maintained for over 2 years.[51] Human uveal 
melanoma cell lines were established and maintained in culture for up to 2.5 years by several 
investigators.[52-56] Reports of cell lines from human primary melanomas and metastases are 
abundant and many of these cell lines are available commercially.[50, 57-70] To the authors' 
knowledge, there is no information in the current literature on routine in vitro growth of equine 
melanoma cells. Doyle et al. mention one cell line with over 20 passages established from a 
tumor that was histologically diagnosed as a melanoma when they studied the cytotoxic effects 
of various drugs on equine cells in vitro.[71] Apparently the tumor was taken from a 
Thoroughbred yearling filly. However, it is unclear if the horse was of grey or solid color and 
there is no information on the isolation method or characterization of this cell line. 
 
The objectives of this study were (a) to develop and establish a method for routine isolation 
and cultivation of grey horse melanoma cells, and (b) to characterize cellular growth properties 
in vitro and describe the morphology of seven permanently growing grey horse melanoma cell 
lines. This study was a preliminary study for the long-term goal of developing an autologous 
tumor vaccine for equine melanoma. Once a reliable protocol for equine melanoma cell 
cultures will be established, studies on transfection of melanoma cells with gene constructs 
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and subsequent reinjection into the patient the cells originally were derived from may be 
pursued. 
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3. Materials and Methods 
a) Solutions 
Solutions were prepared according to the following instructions: 
 
Roswell Park Memorial Institute 1640 (RPMI 1640) Rinse Solution 
RPMI 1640 500 ml,a L-Glutamine 10 ml (=4 mM/ml maintenance medium),b Pyruvate 5 ml 
(=0.01 mM/ml maintenance medium),c Antibiotic Mixture 5 ml (=Penicillin G 50 units/ml, and 
Streptomycin sulphate 50 units/ml maintenance medium, respectively)d 
 
Roswell Park Memorial Institute 1640  (RPMI 1640) Culture Medium 
RPMI 1640 Rinse Solution 500 ml, heat inactivated FCS 50 ml (=10%)e 
 
Dispase Solution 
PBS 63 ml,f 0.1 g Dispase (yields 2 units/ml dispase solution)g 
 
Tris-buffered saline (TBS) 
NaCl 8 g,h Tris-Base 3 g,i KCl 0.2 g,j dH20 1 l, adjust to pH 7.4 with HCl
k 
 
Phosphate-buffered saline (PBS) 
NaCl 8 g, KCl, 0.2 g, Na2HPO4 1.44 g,
 l KH2PO4 0.24 g,
m dH20 1 l, adjust to pH 7.4 with HCl 
 
Calcium Stock Solution 
CaCl2 554.93 g,
n TBS 100 mlo 
 
Collagenase Stock Solution 
TBS 3.04 ml, Collagenase 0.1 g (yields 4112 units/ml Collagenase Stock Solution)p 
 
Fetal Calf Serum (FCS) 
Heat inactivation in a water bath at 56°C for 30 minutes 
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Stop Solution 
NaCl 1.35 g, Tris Base 0.6 g, EDTA Salt 0.03 g,q dH2O 0.1 l, adjust to pH 7.4 with concentrated 
HCl 
 
Antibiotic Mixture 
Penicillin G (5000 units/ml), Streptomycin sulphate (5000 units/ml) in normal saline 
 
Work in the cell culture laboratory was carried out under a laminar flow hood. All instruments 
and materials used in the disaggregation process were sterile. Surgical instruments were 
autoclaved before use and solutions were filtered through filter units r or filter discs.s Before use 
all media and solutions were warmed in a water bath at 37 °C. 
 
b) Horses and collection of samples 
14 healthy grey horses were eligible to elective standing excision of one melanoma (Table 1). 
Three horses had removed a second melanoma from a different location at a second visit to the 
clinic. The horses were placed in stocks and sedated with detomidinet (0.01 mg/kg IV) and 
butorphanolu (0.02 mg/kg IV), followed by a continuous rate infusion of detomidine adjusted 
as needed. Immediately before surgery they were administered flunixin megluminev (1 mg/kg 
IV). Tumors with a size of 4 to 20 mm in diameter, good surgical accessibility, and small risk of 
wound healing complications were selected. The hair was clipped and the surgical site 
prepared for aseptic surgery. Local anesthesia was provided by peritumoral infiltration of 
lidocaine 2%w SC. The melanoma was excised applying to standard surgical technique. The 
volume of the excised tumor material was estimated. Immediately following excision a 
peripheral slice of tumor tissue was placed in 4% formalinx and submitted for histologic 
examination. The remaining tissue was placed in sterile Dulbecco's phosphate buffered saline 
(D-PBS)y containing 1% Antibiotic Mixture at room temperature. It was immediately 
transported to the cell culture laboratory. Time from excision to further processing was 15 to 
20 minutes in all excised tumors. An equine melanoma cell line (kindly provided by Dr. M. 
Seltenhammer, University of Veterinary Medicine, Vienna, Austria) was used as a control and 
was grown under the same conditions as the isolated tumor cells. 
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Table 1: Signalment of horses, location of tumor, and result of experiment. 
Melanoma No. Horse No. Age [yrs] Sex Breed Site Result 
M1 a 16 mc Irish WB Head G 
M2 b 17 mc Swiss WB Pectoral NG 
M3 a# 16 mc Irish WB Head C 
M4 c 20 mc Anglo Arabian Perianal G 
M5 d 21 mc Irish WB Perianal C 
M6 e 13 mc Swiss WB Perianal C 
M7 f 26 mc Andalusian Perianal C 
M8 g 10 mc Lusitano Perianal G 
M9 h 14 f Arabian Perianal G 
M10 i 12 mc Swiss WB Perianal NG 
M11 j 9 mc Dutch WB Head NG 
M12 i# 12 mc Swiss WB Perianal G/NG* 
M13 f# 26 mc Andalusian Perianal NG 
M14 k 12 mc Andalusian Perianal G 
M15 l 8 f Swiss WB Dorsal tail NG 
M16 m 6 m Andalusian Perianal G 
M17 n 9 f Arabian Ventral tail G 
Abbreviations: m=male intact, mc=male castrated, f=female, WB=warm blood, G=cell growth, NG=no cell growth, C=contamination,
 
#second visit, *initial growth followed by cell death for unknown reason. 
 
c) Method of cultivation 
Working under absolutely aseptic conditions is very important when dealing with primary cell 
cultures. Any handling of the tumor or cell culture should only be carried out in a laminar flow 
hood. All instruments used must be sterile. Wearing gloves and wiping anything carried into 
the laminar flow hood with ethanol is recommended. Melanoma cells were dissociated from 
the tumors by two slightly different enzymatic digestion protocols. Both protocols were 
employed simultaneously on each tumor. Protocol A included incubation with the enzyme 
dispase for 3 hours, followed by incubation with the second enzyme collagenase for 2 hours. 
Protocol B was identical except for longer incubation time: Incubation with dispase and 
collagenase were continued for one additional hour, respectively. The melanoma was placed in 
a tissue culture dishz and rinsed with D-PBS containing 1% Antibiotic Mixture. The mass was 
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trimmed free of overlying epidermis, surrounding connective tissue, and fat tissue. This was 
done for two reasons: To get rid of any potentially infected tissue (epidermis) and to obtain 
pure melanoma tissue with only a minimal amount of other cell types. Each tumor was split in 
two pieces. With scalpels and scissors the cleaned halves were minced into very small pieces. 
The larger the total surface the more cells can be isolated by enzymatic digestion from the solid 
tissue. When processing the tissue, care must be taken to work quickly and to avoid any 
unnecessary delay until the cells are placed in the culture medium. Pieces were transferred in 
equal parts to two 50 ml Falcon tubes.aa Each falcon tube had previously been filled with 5 ml 
Dispase Solution (=10 units), 5 ml RPMI 1640 Rinse Solution, and 0.1 ml Antibiotic Mixture 
each. The lids of the Falcon tubes were placed slightly loosened to allow for gas exchange. 
They were placed in a water bath at 37 °C for 3 and 4 hours, respectively. Every 30 minutes 
they were agitated gently by hand. After its respective incubation time each tube was removed 
from the water bath and the lids were closed securely. This was followed by centrifugation at 
2000 rpm for 5 minutes at room temperature. The supernatant was discarded by suction. The 
remaining pellet was suspended in 13.35 ml Tris-buffered saline (TBS), 1.5 ml Calcium Stock 
Solution, 0.15 ml Collagenase Solution (= 617 collagen digestion units), and 0.15 ml Antibiotic 
Mixture. After thorough mixing of the contents the lids of the Falcon tubes were slightly 
loosened again. The tubes were replaced in the water bath for 2 and 3 hours, respectively. 
They were centrifuged and the supernatant was removed. The pellet was suspended in 2 ml 
Stop Solution at 4 °C, left aside for 5 minutes at room temperature, centrifuged at 2000 rpm 
for 5 minutes, and the supernatant was removed. The pellet was suspended with 10 ml RPMI 
1640 Culture Media, centrifuged at 2000 rpm for 5 minutes, and the supernatant removed. 
The last cycle was repeated twice. Before the last centrifugation the suspension was filtered 
through a 70 µm pore filter.bb The final cell pellet was suspended with 2 to 4 ml RPMI 1640 
Culture Medium containing 10% FCS, 2% glutamine, 1% pyruvate, and 1% Antibiotic 
Mixture. Depending on the cell density the suspension was added to 2 to 4 tissue culture 
dishes containing 10 ml RPMI 1640 Culture Medium. The tissue culture dishes were transferred 
to a humidified incubator gassed with 5% CO2 at 37 °C. 
 
All cultures were examined daily for evidence of growth and adherence, using an inverted light 
microscope. RPMI 1640 Culture Medium was replaced 1-3 times a week. When cultures 
obtained >90% confluency, cells were sub cultured diluted at ratios of 1:2 or 1:3. All culture 
media was discarded by suction. The adherent cells were washed with 10 ml D-PBS. All fluid 
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was removed by suction. One ml of 0.5% trypsin-0.2% Na2Ethylenediamine tetra-acetic acid 
(EDTA) in Hanks' Balanced Salt Solution (HBSS) without Ca2+, Mg2+, and phenol red was added 
to the dish.cc It was placed in the humidified incubator at 37 °C and repeatedly observed under 
the inverted light microscope until complete detachment of the cells was detected. The 
enzymatic reaction was stopped by adding 5 ml of RPMI 1640 Culture Medium to the tissue 
culture dish. The cell suspension was transferred to a 15 ml Falcon tube and centrifuged at 
2000 rpm for 5 minutes. The supernatant was removed by suction. The pellet was suspended 
in cell culture medium and added to 2 to 4 new tissue culture dishes as described above.  
Samples of all generations of each cell line were frozen in liquid nitrogen. The protocol for this 
procedure followed the sub culturing-protocol described above. Instead of adding cell culture 
medium to the cells, they were suspended in Cell Culture Freezing Medium-DMSO.dd The 
suspension was dispensed into multiple cryotubesee depending on the cell density. The 
cryotubes were placed on ice for 30 minutes, then transferred to a -70 °C freezer for 24 hours, 
and finally stored at -196 °C in liquid nitrogen until further use. For renewed activation of cell 
growth or further experiments the liquid nitrogen stabilates were removed from the liquid 
nitrogen freezer and immediately thawed in a warm water bath at 37 °C. The suspensions 
were seeded on a tissue culture dish with RPMI 1640 Culture Medium at 37 °C as described 
above. 
 
d) Characterization of tumors and cell lines 
Localization: To document external morphology, tumors M3-M11 and M15-M17 were 
photographed in vivo before excision.  
 
Histology: Of tumors M2-M17 a peripheral tissue slice was placed in 4% formalin immediately 
following surgical excision. M1 was part of a preliminary cell culture study when no histology 
examination was initiated yet. Four-µm-thick, paraffin embedded tissue sections were obtained 
and stained with hematoxylin and eosin for histopathology. They were examined for the 
following characteristics: Ulceration of the epidermis, encapsulation of the tumor, shape, 
symmetry, adnexal involvement, junctional activity, pattern of growth (invasive, expansive), 
vascularization, presence of necrotic areas, cellular composition, presence of inflammatory cells 
and melanophages, apoptosis, mitotic figures, pigmentation, size and shape of the cells, size 
and shape of the nuclei, and presence of nucleoli. Tumor classification was not performed. 
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Light microscopy: Cells were photographed through a phase-contrast microscope by using an 
inverted microscope equipped with phase-contrast lenses as they grew in vitro. Cell 
morphology, cell size and shape, alignment of cells, group pattern, interactions between cells, 
pigment production, and any other interesting feature were documented. 
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4. Results 
a) Success rate of establishing melanoma cell lines in culture 
A total of 17 tumors were harvested and processed. Establishment of a cell line was successful 
in 7 cases (M1, M4, M8, M9, M14, M16, M17) from 7 horses (Table 2). One tumor (M12) 
grew in very few and large individual cells, which died for unknown reasons after 2 divisions. 
Five tumors completely failed to grow (M2, M10, M11, M13, M15). Four cell cultures had to 
be discarded because of  contamination in the first week after isolation and before any cell 
growth was observed (M3, M5, M6, M7). Bacteriologic examination of culture media revealed 
contamination with Streptococcus spp. The success rate to establish continuous cell lines from 
primary tumors was 41% when counting all cultures (7/17), and 54% when counting the non-
contaminated cultures only (7/13). Since no statement can be made about success or failure of 
the cell cultures that had to be discarded because of contamination those cultures will not be 
further discussed in the sections below. 
 
b) Morphology of tumors 
The morphology data of the successful cell lines are summarized in Table 2. The tumors 
originated from the perianal region (5/7), the head (1/7), and the ventral tail base (1/7) (Figs. 
1-3). The tumors were located subcutaneously (4/7), intradermally (1/7), or both (2/7). The 
volume of the tumor tissue available for disaggregation corresponded to about two thirds of 
the original tumor material excised. It ranged from 0.3-5.0 cm3. Most of the tumors were 
perfectly round in shape (5/7), some were rather oval (1/7) or irregularly shaped (1/7). All 
tumors, successful and unsuccessful alike, had a deep black surface on cut sections. Five 
tumors possessed a rubber-like consistency and were hard to cut. Two tumors were firm on 
palpation but rather soft to cut. 
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Table 2: Description of tumors that yielded successful cell lines. 
No. Site Layer Volume [cm3] Shape Color Solidity Demarcation 
M1 Head sc 5.0  oval black very firm good, encapsulated in 
connective tissue 
M4 Perianal id 0.5 round black very firm diffuse,  mixed with large 
amount of connective tissue 
M8 Perianal id, sc 1.0 round black soft good, easy to cut 
M9 Perianal sc 0.5 round black soft good, easy to cut 
M14 Perianal sc 1.0 round black firm good 
M16 Perianal sc 1.0 round black firm good 
M17 Tail base id, sc 0.3 irregular black firm diffuse 
Abbreviations: sc=subcutaneous, id=intradermal 
 
 
 
Figures 1-3: Examples of melanomas in vivo. All three tumors were grown successfully. 
   
(From left to right) Fig. 1: Melanoma 4. Multiple, severe perianal melanomas. Fig. 2: Melanoma 8. Multiple, nodular perianal melanomas. 
Fig. 3: Melanoma 17. Melanoma is located on the ventral tail base. Picture is taken immediately before excision. The skin is incised already.  
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Tumor M12, which grew initially and then died, was located in the perianal region. It was a 
small tumor with a volume of only about 4 mm3. The tumor was round, firm, and hard to cut. 
Very little cell material was yielded after enzymatic digestion. Two of the 5 unsuccessful tumors 
originated from the perianal region, the remaining 3 tumors were from the head, dorsal tail, 
and pectoral region, respectively (Figs. 4-6). Two were located intradermally, one was 
subcutaneously, and one was both. An exception was tumor M2. It was very large (estimated 
6x4x4 cm) and located in the pectoral region deeply embedded between muscle tissues at 
about 8 cm from the skin. Because of the size and location only a wedge biopsy of about 6 cm3 
was taken. The surface of the tumor was covered with connective tissue. It was very easy to 
cut, the central material of the tumor was almost liquid and there was very little intratumoral 
connective or fat tissue. Large amounts of free, heavily pigmented, necrotic material was 
present. M10 was round, had a volume of 1.5 cm3, and revealed identical necrotic features as 
M2. M11 was round, 2 cm3 in volume, firm with few connective and fat tissue. M13 was 
round, 1cm3 large, with a lot of free pigmented material, and not well demarcated. M15 was 2 
cm3 large, round, firm, and hard to cut. 
 
 
 
Figures 4-6: Examples of melanomas in vivo that could not be grown in vitro. 
   
(From left to right) Fig. 4: Melanoma 10. Multiple, isolated perianal melanomas. Fig. 5: Melanoma 11. Single, isolated facial melanoma.  
Fig. 6: Melanoma 15. Single, lateral tail base melanoma. The surface is ulcerated. 
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c) Histologic examination 
Six of the 7 successful cell lines originated from tumor material that was examined 
histologically (Figs. 7-12) On histologic examination all six melanomas were not encapsulated 
and appeared to grow invasively. One tumor had junctional activity (M9). Some masses 
consisted of more than one cell type. Cell morphology of the neoplastic cells varied from round, 
polygonal, to spindloid. Occasionally dendritic cells were identified. No apoptotic cells were 
present and no mitotic figures were observed in any of the melanoma cells. The cytoplasm 
contained little to abundant melanin. The nuclei were typically round to ovoid and 
euchromatic. They contained one or more prominent nucleoli. There was a mild degree of 
anisokaryosis and moderate polymorphism of the nuclei and cells. The histologic diagnoses 
were melanoma (M4), moderately malignant melanoma (M16, M17), and malignant 
melanoma (M8, M9, M14). All tumors were considered at risk for relapse and formation of 
metastasis. 
 
 All the unsuccessful tumors, including tumor M12, which died after two divisions, grew 
invasively (Figs. 13-18). M15 was the only tumor with ulceration of the epidermis. Three 
tumors were necrotic in the center (M2, M10, M13). None of the tumors were encapsulated. 
Four tumors contained large amounts of connective tissue. The tumor shape varied from oval 
to asymmetrical. Four tumors had adnexal involvement. Two tumors showed junctional activity 
(M11, M15). Vascularization was good in all tumors. No apoptosis was present. M15 had 
mitotic figures. Pigmentation was rather coarse except for M13, which was finely granulated. 
Cell shapes were similar to the successful tumors described above but none of the cells had a 
dendritic appearance. The cells were larger compared to the successful tumor cells. Nuclei, 
nucleoli, pigment content of the cells, and anisokaryosis were comparable to the successful 
melanomas. Histologic diagnoses were melanoma (M2) and malignant melanoma (M10-M13, 
M15). All tumors were considered at risk for relapse and formation of metastasis. 
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Figures 7-12: Histologic examination of successful tumors. 
 
Fig. 7: Melanoma M4. 1x (left) and 40x (right) 
 
 
Fig. 8: Melanoma M8. 4x (left) and 20x (right) 
 
 
Fig. 9: Melanoma M9. 4x (left) and 40x (right). Junctional activity. 
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Fig. 10: Melanoma M14. 10x (left) and 40x (right) 
 
 
Fig. 11: Melanoma M16. 10x (left) and 40x (right) 
 
 
Fig. 12: Melanoma M17. 1x (left) and 40x (right) 
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 Figures 13-18: Histologic examination of unsuccessful tumors. 
  
Fig. 13: Melanoma M2. 4x (left) and 20x (right). Necrotic center. 
 
 
Fig. 14: Melanoma M10. 1x (left) and 20x (right). Necrotic center. 
 
 
Fig. 15: Melanoma M11. 4x (left) and 20x (right) 
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Fig. 16: Melanoma M12. 1x (left) and 40x (right) 
 
 
Fig. 17: Melanoma M13. 4x (left) and 20x (right). Necrotic center. 
 
 
Fig. 18: Melanoma M15. 1x (left) and 40x (right). Ulcerated epidermis. 
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d) Cell culture growth and morphology 
All successful cell lines grew as adherent monolayer cultures in tissue culture dishes. Cellular 
morphology when evaluated by an inverted microscope was similar in most cell lines. Cell lines 
M1, M4, M8, M14, M16, and M17 were comprised of spindle shaped to dendritic cells (Figs. 
19-26). Some cells had very long dendritic processes. They had a low nuclear-to-cytoplasmatic 
ratio with round to oval nuclei, multiple dark nucleoli, and well-defined cytoplasmic borders. In 
cell line M9 an additional cell type to the ones described above was detected. Those cells were 
epithelioid and smaller than the dendritic cells. They grew in a denser pattern building sheet-
like structures. Pigment production was evident in all primary cell cultures. The cells were of 
very faint light brown color. The cells grew in clusters with dark brown, granular accumulation 
of extracellular pigment in the center. Cell line M14 was unique in that a large percentage of 
its cells had intracytoplasmatic small melanin granules instead of the large extracellular 
deposits. It appeared that in general the cells became amelanotic and ceased producing 
melanin after being sub cultured. They were smaller and less dendritic compared to the primary 
culture. The control equine melanoma cell lines consisted of amelanotic, very small, polygonal 
cells that grew in sheets (Fig. 27). 
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Figures 19-27: Primary cell cultures in vitro. 
 
Fig. 19: Melanoma M1. Day 31. Cell clusters with central pigment deposits. 
 
 
 
Fig. 20: Melanoma M4. Day 21. Cell clusters with central pigment deposits. Note long dendrites of cells. 
 
 
 
Fig. 21: Melanoma M8. Day 102. Large amount of dark pigment deposit (left). Single dendritic cell with intracellular pigment granules (right). 
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Fig. 22: Melanoma M9. Day 14. Long dendrite reaching out on top of other cells to make contact (left). Two different cell types: Epitheloid, 
round cells and spindloid, dendritic cells. 
 
 
Fig. 23: Melanoma M12. Day 99. Large individual cells without den- 
drites and no clustering behaviour. Cells died after 2 divisions. 
 
 
Fig. 24: Melanoma M14. Day 32. Large cells with intracytoplasmatic pigment granules. Other cells are smaller but also dendritic. 
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Fig. 25: Melanoma M16. Day 93. Small single cells.  
 
 
 
Fig. 26: Melanoma M17. Day 66. Spindloid, dendritic cells. 
 
 
 
Fig. 27: Control melanoma cell line. Amelanotic, small, polygonal cells growing in sheets. Occasional dendrites. 
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First adherence of the suspended cells was observed between 2-18 days after isolation (Table 
3). Cells of M9 adhered after 2 days already. By contrast, the cells of M12, which died for 
unknown reasons after 2 divisions, took 40 days until they showed evidence of adherence. 
Once single cells were adhered to the culture dish, their division lead to an accumulation of 
adhered cells in close relationship. In general, multiple islands of cell clusters were present on 
the Petri dish after a while. The point of time when confluency of the cells on the culture dish 
was reached varied widely. The fastest growing cell culture was confluent after 10 days, 
whereas the slowest growing culture took 100 days after initiation. Even though the cell 
cultures grew with different characteristics, the speed of growth was relatively constant among 
one cell culture. M8 was the slowest culture. It was the last one to reach confluency and 
continued to grow very slowly after being sub cultured. 
 
 
 
 
Table 3: Starting days of adherence and confluency after initiation of the cell cultures. 
Melanoma Day of adherence Day of confluency 
M1 6 10 
M4 8 42 
M8 7 100 
M9 2 36 
M12* 40 died before 
M14 10 60 
M16 18 41 
M17 13 56 
*) Cell culture that died after 2 divisions 
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5. Discussion 
With the described method for isolation and cultivation it was possible to successfully isolate 
and cultivate 7 grey horse melanomas. Cellular growth properties and cell morphology were 
observed in vitro and described for the first time. The donor horses were selected according to 
their availability and owners consent only. No consideration was given to breed, age, gender, 
localization, or size of tumor. Six different breeds contributed to the 7 successful cell lines. The 
distribution of gender (4 geldings, 2 mares, and 1 stallion) reflects the general horse 
population seen at the Equine Hospital at the University of Zurich. The age of the animals 
ranged from 6-20 years, representing the known age span of first melanoma appearance in 
grey horses. No obvious impact of breed, age, and gender of the donor horses on the outcome 
of a successful cell culture was noted.  
 
The surgical protocol for standing excision served the purpose. Sedation and analgesia of the 
horses with detomidine and butorphanol was sufficient to allow excision of the tumors in a 
quiet and efficient matter. No adverse side effects were observed in any of the horses. Apart 
from occasional dehiscence of solitary sutures, wound healing was uncomplicated in all horses. 
No further medical or surgical treatment was necessary. It is of paramount importance that the 
surgical excision is carried out under aseptic conditions. Not only for an uncomplicated wound 
healing in the patient but primarily to ensure sterility of the tumor tissue. In primary cell 
cultures any source of contamination must be avoided at all means. Potential infectious agents 
could be carried into the cell culture laboratory with the primary tissue. Infected cell cultures 
must be discarded immediately. Normally they can not be saved and they put other cultures in 
the same incubator in danger. 
  
The tumor material was immediately placed in sterile D-PBS with 1% Antibiotic Mixture at 
room temperature and transported to the cell culture laboratory within 15 to 20 minutes. The 
effects of transporting the tissue in another type of sterile fluid, the addition of various 
nutrients, antibiotics, antimycotics, and keeping the tissue at body temperature at all times  
remains unknown and requires further studies. There might be an improvement in the outcome 
if the tissue was minced into little pieces already at the time of excision. This results in a larger 
surface area for equilibration with the D-PBS. As we were successful in seven tumors we 
believe that our procedure is sufficient and does not necessarily need adaptations. The faster a 
tissue is processed after collection the more viable its cells are.[72] Even though 15 minutes is a 
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short time between excision and isolation we believe direct processing of the melanoma would 
yield an even better outcome. On the contrary, it must be assumed that prolonged storage time 
of several hours results in more non-viable cells and therefore a worse outcome. The effect of 
freezing the tumor tissue in liquid nitrogen and subsequent isolation after several days, weeks, 
or even months must be studied further. Immediate freezing would allow the collection of 
melanomas independent of time or place, for example at night time or in an abattoir. 
Collecting tumors from slaughtered horses would be an advantage. It would facilitate rapid 
and sterile tumor collection yielding a large amount of viable tissue. The fact that the excisions 
had to take place in close proximity to the cell culture laboratory and that all involved staff and 
necessary equipment had to be ready at the same time made it difficult to collect a large 
number of tumor samples within a reasonable time frame. 
  
The procedure would be facilitated further if smaller amounts of tumor material would be 
enough for processing, allowing fine needle aspiration biopsies or excisional biopsies to be 
adequate instead of excising whole tumors. Horse owners are less hesitant to have a small 
biopsy taken from their horse than excising an entire tumor. For the horse a biopsy is less 
unpleasant than surgical excision. The fact that the tumor remains for further analyses before, 
during, and after prospective therapy, represents an additional advantage.[66] 
  
Both applied enzymatic digestion protocols yielded the same results. If incubation was 
successful in a tumor, both attempts worked. However, if time allows, the protocol could be 
prolonged for both enzymes or the minced tissue could be incubated overnight. The effect of 
these changes to the procedure might improve isolation and should be studied further. Using 
dispase and collagenase as digestion enzymes worked well. While other enzymes might be 
used instead, we did not examine the effects of different enzymatic assays. Collagenase is 
costly, therefore it would be desirable to replace it with a less expensive enzyme. RPMI 1640 
growth medium must be present at all times to ensure adequate nutrition and equilibration of 
the tissue and isolated cells. The temperature of the water bath should be at body temperature 
for optimal enzymatic conditions. Colder temperature demands longer incubation times 
resulting in a higher risk of cell death. Higher temperature kills the cells and might slow down 
or even stop enzymatic disaggregation. To filter the cell suspension before the last 
centrifugation proved useful. Large clumps of undigested tissue and remaining connective 
tissue could be discarded resulting in a relatively pure cell suspension. Maintenance of the cell 
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cultures was conducted according to standard cell culture practice for mammalian cells. 
Because many factors contribute to successful growth of a culture it is impossible to assess the 
influence of any single factor. 
  
Temperature, humidity, growth medium, supplements, oxygen and carbon dioxide 
concentration, pH, osmolality, culture flask or dish, and other factors may have influenced the 
outcome of our melanoma cell cultures. These effects need further investigation to decide if 
better growth conditions for equine melanoma cells are possible. Seven of 17 tumors yielded 
continuously growing cell lines. The success rate of establishing melanoma cell lines of 41%, or 
54% not including the contaminated cultures, contrasts reported success rates of 70-90% in 
human medicine,[66] or 81% in swine.[44] Procedures in human medicine are very advanced 
because of longstanding experience and a large availability of tumor material. Obstacles in our 
study were the difficulty of recruiting a large number of donor horses due to owner's hesitance 
and the strict requirements for the procedure we set. No information about experience with 
grey horse cell culture was found in the current literature. For these reasons we are satisfied 
with our success rate for this point of time. However, further studies are needed to optimize 
collection techniques of tumor material and improve cell culture methods. Melanoma M12 cells 
died after 2 divisions for unknown reasons. The cells of this melanoma had an atypical 
appearance and growing pattern when compared to the successful seven. Either they 
experienced programmed cell death or they needed different growing conditions. The exact 
cause of cell death is only speculative. The 4 cell cultures that were contaminated illustrate the 
importance of avoiding infection. They could not be salvaged and had to be discarded before 
any adherence or growth was observed. It is unknown if without contamination those cultures 
would have been successful. The time of adherence varied between 2-18 days in the successful 
cultures and the discarded cultures did not survive for more than one week. Because all 
cultures showed signs of contamination on the same day it was assumed that the infectious 
agent had been transmitted from one contaminated culture to the others by means of 
contaminated media, instruments or non-sterile handling. 
  
Six tumors failed to grow in vitro. The inability to establish cell lines from those tumors may 
have been to the result of medium constituents, selection for non-viable cells in the tumors, or 
any cell characteristics requiring handling that was not adequately met. Cells grow in vivo with 
close interactions with adjunct cells. In vitro those mechanisms are lacking and therefore 
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growth conditions are not ideal. In swine it was shown that samples, which failed to grow, 
were derived from ulcerated, melanin-exuding lesions which consisted of free melanosomes 
and few cells.[44] We experienced similar effects (see below). 
  
The tumor site did not seem to influence the outcome of a cell culture. Even though tumors 
from the perianal region and tail predominated in the horses that were presented, one of the 
successful tumors originated from the head. Intradermal tumor location did not affect outcome, 
however, both surgical excision and further processing in the cell culture laboratory were more 
complicated. It was faster and easier to get rid of connective and fat tissue but dissection of 
the frequently strongly attached epidermis from the melanoma was more difficult. Different 
consistencies of the tumors lead to several problems. Very firm tumors were hard to mince into 
little pieces and therefore took longer to process until being incubated with growth medium in 
the first dissociation step. Several of the unsuccessful tumors were soft and necrotic in the 
center, with black fluid leaking out. Only an intact outer layer was present (Fig.13). Therefore, 
it was of benefit to discard all necrotic tissue and use peripheral, "healthy" tissue only. 
However, this is difficult to assess visually and requests experience by the handler. Free 
necrotic tissue and pigment could potentially disturb cell growth in the final cell culture. 
Pigment could not be discarded by filtering. It tended to adhere to the culture dish and was 
hard to remove by changing the culture medium. Hence, it was important to avoid adding free 
pigment to the cell culture in the first place. In the authors’ experience the smaller a tumor, the 
better were its processing characteristics. It appeared that the larger tumors contained more 
necrotic areas and had worse growing properties, such as observed in melanoma M2. 
Therefore it is recommended to excise whenever possible small, well confirmed, subcutaneous 
melanomas. 
 
All submitted melanomas were confirmed histologically. In the tumors of the unsuccessful 
group there were tendencies toward more central necrosis and/or a larger amount of 
connective tissue. The histologic findings corresponded to the macroscopic findings discussed 
above. Abundant connective tissue interfered with the processing of the melanoma and yields 
a proportionally smaller amount of isolated melanoma cells. Fibroblasts and stromal tissue cells 
are difficult to filter away from the tumor cells, which may result in fibroblast overgrowth.[66] 
The cells of the unsuccessful tumors were not dendritic in shape, whereas some of the 
successful cells had dendrites. Dendrites are an important organ of melanocytes in vivo. It 
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enables the cell to interact with neighboring cells and transfer melanin.[73] There might be a 
better potential for in vitro growth for cells that have dendrites in vivo already. 
  
Cells in the unsuccessful group were generally larger than in the successful group. Size could 
have an impact on a cell's ability to survive when isolated and grown in a cell culture. 
However, the reasons for different behavior must be studied further. Improved histologic 
characterization would have been possible if strongly pigmented melanomas would have been 
bleached. This procedure enables better interpretation of the nuclei in regard to morphology, 
pleomorphism, and presence of mitotic figures resulting in a more reliable decision on 
malignancy.[12, 74] Cellular morphology was similar in most melanoma cells in vitro. Even though 
cancer cells are degenerated, the spindle shape and dendritic processes in the primary cultures 
may reflect characteristics of what is known of normal melanocytes in vivo. Melanocytes are 
located in the basal cell layer of the epidermis and in hair follicles.[73] They have dendritic 
processes that intussuscept into the surrounding keratinocytes. Horses have one melanocyte 
per 10 to 20 keratinocytes.[75] Synthesis of melanin takes place within specialized intracellular 
organelles called melanosomes. After production the pigment is stored in granula and 
transported to the dendritic processes. There, the melanin granula are transferred to adjacent 
cells.[76] In keratinocytes melanin granules are often clustered dorsal to the nucleus.[75] The 
cultured melanoma cells showed a similar tendency. Dark brown pigment was produced and 
excreted extracellularly. The pigment clustered in the center of a group of cells. The presence of 
dark brown pigment and the cell's typical behavior strongly suggests that the cells really were 
melanoma cells. Up-regulation of melanogenesis in melanoma is unknown in horses, but has 
been shown in other species.[77] 
  
All grey horse melanomas were dark black on cut surface and there was obvious pigment 
production in the cell cultures. This observation would support this theory in horses as well. 
Beyond primary culture the cells seemed to be smaller and less dendritic. They appeared less 
melanotic or even amelanotic. It appeared that the melanin-producing ability was lost after the 
first passages. Normal melanocytes are in close relationship with keratinocytes, called the 
epidermal melanin unit.[73, 75] However, melanoma cells grow in an expansive and uncontrolled 
manner. Whether melanoma cells in vitro would profit from interaction with some kind of other 
cell type is unknown. In our cell cultures growth was possible without any scaffold or support. 
The addition of other cells could interfere with characterization experiments and therefore is 
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not recommended. Initially, there was a wide range of adherence and speed of cell growth. In 
porcine melanoma, growth characteristics of cell cultures varied with the age of the swine from 
which the tumors were obtained.[44] Cell cultures obtained from swine younger than 2 months 
grew steadily and rapidly with cell division ceasing after 6-8 passages. Cell cultures of tumors 
obtained from swine aged 3 months or older showed a biphasic growth pattern with an early 
slow growth rate. However, they lived longer and terminated growth after 18-20 passages. 
The effect of the donor horse's age on cell culture growth characteristics remains to be 
examined. 
 
The objectives of our study were to establish a novel method for isolation of grey horse 
melanoma cells and to study the histology of the tumor and the morphology of the cell line 
originating from it. Limitations in our study were that several routine examinations of cell lines 
were not performed. This includes population doubling times, number of passages until 
termination of cell division and growth, and electron microscopy examinations. In melanoma 
cells melanin-synthesizing characteristics such as DOPA-oxidase histochemistry and melanin 
spectroscopy of the culture medium would have been of interest.[44] 
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6. Conclusion 
A method to successfully isolate grey horse melanoma cells and to establish cell lines is 
described. Seven permanently growing cell lines were established, representing a success rate 
of 41%. Tumors of various locations in horses of different breeds, ages, and genders were 
cultivated with no apparent difference in success. The cells adhered after 2-18 days and 
reached confluency after 10-100 days. In vitro the cells appeared dendritic and produced 
pigment, which clustered extracellularly. Further studies to improve the described protocol 
should include examination of different excision protocols, changes in tumor storage, and the 
exploration of various growing conditions on the outcome of cell cultures. The cell lines that 
were established should be characterized with experiments using specific melanoma antigens. 
If this method of obtaining and establishing tumor cell lines of grey horse melanomas reaches 
a near 100% success rate, investigations on immunobiologic and pathobiologic features of 
equine melanoma are possible and research on effective melanoma therapy in horses can be 
advanced. 
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7. Footnotes 
a. Roswell Park Memorial Institute 1640 medium (1x) liq., 21870-076, Invitrogen 
Corporation, Paisley, UK 
b. L-Glutamine 200mM, liq., 25030-024, Invitrogen Corporation, Paisley, UK 
c. Sodium pyruvate 100mM, liq., 11360, Invitrogen Corporation, Paisley, UK 
d. Penicillin/Streptomycin Sol. (5000:5000), liq., 15070-063, Invitrogen Corporation, 
Paisley, UK 
e. ES cell qualified fetal bovine serum, 16141-079, Invitrogen Corporation, Paisley, UK 
f. Phosphate-buffered saline, (1x), liq., 10010-015, Invitrogen Corporation, Paisley, UK 
g. Dispase, 17105-041, Invitrogen Corporation, Paisley, UK 
h. Sodium chloride, 71378, FLUKA, Sigma-Aldrich Corporation, Buchs 
i. Tris (Hydroxymethyl) aminomethane, 44333, BIOSOLVE, Valkenswaard, Netherlands 
j. Potassium chloride, P9333, Sigma-Aldrich Corporation, Buchs 
k. Hydrochloric acid, 320331, Sigma-Aldrich Corporation, Buchs 
l. Sodium phosphate dibasic, S7907, Sigma-Aldrich Corporation, Buchs 
m. Potassium phosphate monobasic, P0662, Sigma-Aldrich Corporation, Buchs 
n. Calcium chloride, C1016, Sigma-Aldrich Corporation, Buchs 
o. Tris-buffered saline, own stock 
p. Collagenase from Clostridium histolyticum, C2674, Sigma-Aldrich Corporation, Buchs 
q. Ethylenediaminetetraacetic acid disodium sulfate (EDTA), 03679, FLUKA, Sigma-
Aldrich Corporation, Buchs  
r. Steritop-GP filter unit, SCGPT05RE, Millipore, Billerica, MA, USA 
s. Puradisc™ FP30/0.45/0.2 CA-S, Whatman Switzerland GmbH, Bottmingen 
t. Domosedan, Pfizer AG, Zürich 
u. Morphasol, Dr. E. Graeub AG, Bern 
v. Fluniximin, Berna Veterinärprodukte AG, Bern 
w. Lidokain Hyaluronidase 2%, G.Streuli & Co. AG, Uznach 
x. Formalinlösung 4% gepuffert pH7, Kantonsapotheke Zürich 
y. D-PBS (1x), liq., without Ca, Mg, Phenol Red, 14190-094, Invitrogen Corporation, 
Paisley, UK 
z. Tissue culture dish 100/20mm, 664160, Greiner Bio-One GmbH, Frickenhausen, 
Germany 
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aa. BD Falcon™ Conical Centrifuge Tubes, 15ml (352096) and 50ml (352070), BD 
Biosciences, Allschwil 
bb. BD Falcon™ Cell Strainers, 70um, 352350, BD Biosciences, Allschwil 
cc. Trypsin-EDTA solution, T3924, Sigma-Aldrich Corporation, Buchs 
dd. Cell culture freezing medium, 11101-011, Invitrogen Corporation, Paisley, UK 
ee. Nunc CryoTubes™, 366656, Nunc GmbH & Co. KG, Wiesbaden, Germany 
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